Viewing StudyNCT00472329



Ignite Creation Date: 2024-05-05 @ 5:32 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00472329
Status: UNKNOWN
Last Update Posted: 2014-06-30
First Post: 2007-05-10

Brief Title: Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
Sponsor: Colorado Blood Cancer Institute
Organization: Colorado Blood Cancer Institute

Organization Data

Organization: Colorado Blood Cancer Institute
Class: OTHER
Study ID: RMBMT-166-A
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Colorado Blood Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Peter McSweeney MD
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Colorado Blood Cancer Institute
Old Name: None
Old Organization: None

Collaborators